CMAC 2012; 14(2) | CMAC

CMAC 2012; 14(2)

Pseudomonas aeruginosa is the opportunistic microorganism dominating in intensive care units. The present research has been devoted to …
Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(2):88-99
PDF

Objective. To determine significance of Legionella pneumonia for hematological patients in ICUs, and to evaluate prospects of the …
Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(2):100-106
PDF

Long-term dialysis therapy in patients with chronic kidney disease is usually associated with vascular access problems, mechanic and …
Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(2):107-117
PDF

Bacterial infections in orthopedic and reconstructive surgery are associated with significant morbidity and poor functional outcomes. …
Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(2):118-131
PDF

The prevalence and molecular epidemiology of MBLproducing Gram-negative bacteria have been studied in Russia (1998–2010), Belarus and …
Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(2):132-152
PDF

Here we report on a high incidence of quinolone resistance (43,1%) among nosocomial CTX-M-5 ESBLproducing S. Typhimurium isolates …
Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(2):153-161
PDF

Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(2):162-164
PDF

Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(2):165-166
PDF

The retrospective analysis of treatment of patients with severe community-acquired pneumonia has been performed. It has demonstrated …
Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(2):167-169
PDF